Products

Bonus BioGroup is developing an innovative tissue engineering technology to produce cell-based therapies:

BonoFillTM: A personalized, viable bone graft for bone tissue repair that is specifically tailored to the biological, physical and clinical needs of each patient.

MesenCure: Bonus BioGroup has joined the global efforts to fight the novel coronavirus (COVID-19) pandemic outbreak, and is currently developing an advanced, cell therapy for the attenuation of the life-threatening acute respiratory distress in COVID-19 pneumonia.

FOR MORE INVESTOR RELATION INFORMATION

Press Release, Announcements publication and more

Bonus BioGroup

Image

 

Terms of UsePrivacy Policy | Login        

© 2021 Bonus BioGroup Ltd. All Rights Reserved. Designed By Netron Israel Ltd.
Accessibility Initiative Badge